Wilensky R L, March K L, Gradus-Pizlo I, Schauwecker D, Michaels M B, Robinson J, Carlson K, Hathaway D R
Indiana University School of Medicine, Indianapolis, USA.
Am Heart J. 1995 May;129(5):852-9. doi: 10.1016/0002-8703(95)90103-5.
Catheter-mediated intramural delivery of pharmaceutical agents after angioplasty is a potential method to reduce postangioplasty restenosis. The efficacy of such delivery has been limited both by an incomplete initial intramural deposition of delivered agents and by rapid diffusion of soluble agents from the site of delivery. The local delivery of microparticulate agents results in prolonged retention of material at the delivery site. Accordingly this study was designed to evaluate the complementary issue of the initial delivery efficiency and pattern of localization of microparticles after local catheter-mediated delivery with two types of porous balloons. These two types were a "standard" porous balloon (PB) in which hydraulic pressure both inflated the balloon and infused the agents and a porous balloon with a mechanical undergirding that permitted mechanical expansion (PB/ME) before agent infusion. Radioactive cerium 141-labeled microparticles (11.4 microns diameter) were locally delivered into atherosclerotic rabbit femoral arteries after angioplasty to test the hypothesis that use of the PB/ME apparatus would yield enhanced intramural particle deposition and decreased systemic administration by increased balloon-wall contact before microparticle infusion. Six animals underwent infusion with the PB catheter, and seven animals underwent infusion with the PB/ME catheter. An image of the in vivo particle distribution was obtained with a gamma camera during infusion, immediately after infusion, and 1, 3, and 7 days after infusion. Tissue samples from the artery, periadventitia, thigh, calf, and foot musculature, and liver were obtained at animal death, and retained radioactivity was measured with a well counter.(ABSTRACT TRUNCATED AT 250 WORDS)
血管成形术后通过导管介导在血管壁内递送药物制剂是一种减少血管成形术后再狭窄的潜在方法。这种递送的效果受到递送制剂初始血管壁内沉积不完全以及可溶性制剂从递送部位快速扩散的限制。微粒制剂的局部递送可使物质在递送部位保留更长时间。因此,本研究旨在评估使用两种类型的多孔球囊进行局部导管介导递送后,微粒的初始递送效率和定位模式这一补充问题。这两种类型分别是“标准”多孔球囊(PB),其通过液压使球囊膨胀并注入制剂;以及一种带有机械支撑的多孔球囊,在注入制剂前允许机械扩张(PB/ME)。血管成形术后,将放射性铈141标记的微粒(直径11.4微米)局部递送至动脉粥样硬化兔的股动脉,以检验以下假设:使用PB/ME装置在微粒注入前通过增加球囊壁接触,可提高血管壁内颗粒沉积并减少全身给药。6只动物用PB导管进行注入,7只动物用PB/ME导管进行注入。在注入过程中、注入后立即以及注入后1天、3天和7天,用γ相机获取体内颗粒分布图像。在动物死亡时获取动脉、外膜、大腿、小腿和足部肌肉组织以及肝脏的组织样本,并用井型计数器测量残留放射性。(摘要截断于250字)